Patents by Inventor Michael Faltys

Michael Faltys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180001096
    Abstract: An implanted stimulator can deliver a patient-detectable electrical stimulation to remind or prompt a patient to interact with an implanted therapeutic device (e.g., neurostimulator) when a prompting event occurs. For example, the apparatuses and methods described herein may be configured to apply a prompting patient-detectable electrical vagus nerve stimulation to remind a patient that it is time to administer a therapeutic dose. When the therapeutic device is operated in an automatic fashion, the apparatus can also deliver a patient-detectable warning stimulation prior to the therapeutic stimulation to let the patient know that a therapeutic stimulation will be delivered soon thereafter.
    Type: Application
    Filed: February 3, 2016
    Publication date: January 4, 2018
    Applicant: SETPOINT MEDICAL CORPORATION
    Inventors: Michael A. FALTYS, Jacob A. LEVINE, Richard A. BLOCK
  • Patent number: 9855425
    Abstract: Information can be stored in a cochlear stimulation system by determining an item of patient specific information, transferring the item of patient specific information to an implantable portion of the cochlear stimulation system, and permanently storing the item of patient specific information in the implantable portion of the cochlear stimulation system. The item of patient specific information can comprise a parameter for use in generating a stimulation current. The implantable portion of the cochlear stimulation system also can be configured to permanently store one or more items of patient specific information in an alterable fashion. Further, an item of patient specific information can be retrieved from the implantable portion of the cochlear stimulation system. Additionally, an item of non-patient specific information for use in processing a received acoustic signal can be determined and permanently stored in an external portion of the cochlear stimulation system.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: January 2, 2018
    Assignee: Advanced Bionics AG
    Inventors: Michael A. Faltys, Timothy J. Starkweather, Anthony K. Arnold
  • Patent number: 9849286
    Abstract: Described herein are systems and methods for applying extremely low duty-cycle stimulation sufficient to treat chronic inflammation using feedback to adjust the off times between stimulations. In particular, the feedback include an assessment of the level of inflammation by the patient or the healthcare provider, or by measure the level of an inflammatory analyte or biomarker, or by detecting nerve activity correlated with inflammation.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: December 26, 2017
    Assignee: SetPoint Medical Corporation
    Inventors: Jacob A. Levine, Michael A. Faltys
  • Publication number: 20170304613
    Abstract: An extravascular nerve cuff that is configured to hold a leadless, integral, implantable microstimulator. The nerve cuff may include a cuff body having a pocket or pouch for removably receiving the implantable device within. The nerve cuff can be secured around the nerve such that the electrodes of the device are stably positioned relative to the nerve. Furthermore, the nerve cuff drives the majority of the current from the stimulation device into the nerve, while shielding surrounding tissues from unwanted stimulation.
    Type: Application
    Filed: July 10, 2017
    Publication date: October 26, 2017
    Inventors: Michael A. FALTYS, Roy C. MARTIN, Steven E. SCOTT, Gerald E. LOEB
  • Publication number: 20170209705
    Abstract: Leadless, implantable microstimulators for treating chronic inflammation. These devices can include a static magnetic field detector (e.g., non-Hall effect sensors/detectors, including those based on a Wiegand effect or generating pulses at a predetermined frequency range and using a detection circuit to determine the decay rate of the pulses), to trigger an emergency shut off of the microstimulator. Also described are methods and apparatuses for regulating the temperature of an implant based applied power from a charger (e.g., voltage across the charger when unloaded and when loaded by the implant) to yield a power control loop correlated with the power drawn by the implant to determine temperature of the implant. A negotiation protocol can exchange data between the charger and the implant (e.g., type of charger, type of implant, nature of the coupling between the two, etc.) to set target power control loop parameters to estimate and regulate implant temperature.
    Type: Application
    Filed: January 25, 2017
    Publication date: July 27, 2017
    Inventors: Michael A. FALTYS, Jesse M. SIMON
  • Publication number: 20170203103
    Abstract: Methods and apparatuses for stimulation of the vagus nerve to treat inflammation including adjusting the stimulation based on one or more metric sensitive to patient response. The one or more metrics may include heart rate variability, level of T regulatory cells, particularly memory T regulatory cells, temperature, etc. Stimulation may be provided through an implantable microstimulator.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 20, 2017
    Inventors: Jacob A. LEVINE, Michael A. FALTYS, Jesse M. SIMON
  • Publication number: 20170202467
    Abstract: Methods and apparatuses (e.g., devices and systems) for vagus nerve stimulation, including (but not limited to) sub-diaphragmatic vagus nerve stimulation. In particular, the methods and apparatuses described herein may be used to stimulate the posterior sub-diaphragmatic vagus nerve to treat inflammation and/or inflammatory disorders. The implantable microstimulators described herein may be inductively charged and/or communicated with using the external charger. The implant may include a receiving antenna wrapped around the battery and/or the housing of the microstimulator/microregulator and/or may include a high magnetic permeability material in order to serve as a magnetic core for the antenna coil. Wearable inductive chargers/communication devices for inductively communicating with (including charging) an implanted microstimulator are described herein, which may include magnetically conductive material to enhance communication with an implant, including sub-diaphragmatic implants.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 20, 2017
    Inventors: Ralph J. ZITNIK, Michael A. FALTYS, Jacob A. LEVINE, Jesse M. SIMON
  • Publication number: 20170197076
    Abstract: A nerve cuff for establishing a nerve block on a nerve can have a cuff body with a channel for receiving a nerve, a reservoir for holding a drug, and an elongate opening slit extending the length of the cuff body that can be opened to provide access to the channel and can be closed to enclose the cuff body around the nerve. The nerve cuff can also include an electrode for detecting and measuring electrical signals generated by the nerve. A controller can be used to control delivery of the drug based on the electrical signals generated by the nerve.
    Type: Application
    Filed: January 13, 2017
    Publication date: July 13, 2017
    Inventors: Michael A. FALTYS, Jacob A. LEVINE, Jesse M. SIMON
  • Patent number: 9700716
    Abstract: An extravascular nerve cuff that is configured to hold a leadless, integral, implantable microstimulator. The nerve cuff may include a cuff body having a pocket or pouch for removably receiving the implantable device within. The nerve cuff can be secured around the nerve such that the electrodes of the device are stably positioned relative to the nerve. Furthermore, the nerve cuff drives the majority of the current from the stimulation device into the nerve, while shielding surrounding tissues from unwanted stimulation.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: July 11, 2017
    Assignee: SetPoint Medical Corporation
    Inventors: Michael A. Faltys, Roy C. Martin, Steven E. Scott, Gerald E. Loeb
  • Patent number: 9668068
    Abstract: A system and method for generating a beamforming signal is disclosed. A beam forming signal is generated by disposing a first microphone and a second microphone in horizontal coplanar alignment. The first and second microphones are used to detect a known signal to generate a first response and a second response. The first response is processed along a first signal path communicatively linked to the first microphone, and the second response is processed along a second signal path communicatively linked to the second microphone. The first and second responses are matched, and the matched responses are combined to generate the beamforming signal on a combined signal path.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: May 30, 2017
    Assignee: Advanced Bionics, LLC
    Inventors: Michael A. Faltys, Abhijit Kulkarni, Scott A. Crawford
  • Patent number: 9662490
    Abstract: Described herein are devices, systems and method of treating inflammation by vagus nerve stimulation and the delivery of an anti-inflammatory drug. In particular, described herein are methods of treating inflammation including the steps of stimulating a subject's inflammatory reflex to inhibit the immune response and administering an anti-inflammatory drug.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: May 30, 2017
    Assignee: The Feinstein Institute for Medical Research
    Inventors: Kevin J. Tracey, Mauricio Rosas-Ballina, Michael A. Faltys, Ralph J. Zitnik
  • Publication number: 20170113044
    Abstract: Devices and methods for stimulation of the vagus nerve to modulate (e.g., reduce, suppress, etc.) bone erosion. Methods and apparatus for modulating bone erosion may modulate levels of Receptor Activator for Nuclear Factor ?B Ligand (RANKL), and/or to modulate (increase, enhance, etc.) osteoprotegerin (OPG) and/or OPG/RANKL ratio. Devices may include electrical stimulation devices that may be implanted, and may be activated to apply current for a proscribed duration, followed by a period without stimulation.
    Type: Application
    Filed: January 4, 2017
    Publication date: April 27, 2017
    Inventors: Jacob A. LEVINE, Michael A. FALTYS, Ralph J. ZITNIK
  • Patent number: 9572983
    Abstract: Devices and methods for stimulation of the vagus nerve to modulate (e.g., reduce, suppress, etc.) bone erosion. Methods and apparatus for modulating bone erosion may modulate levels of Receptor Activator for Nuclear Factor ? B Ligand (RANKL), and/or to modulate (increase, enhance, etc.) osteoprotegerin (OPG) and/or OPG/RANKL ratio. Devices may include electrical stimulation devices that may be implanted, and may be activated to apply current for a proscribed duration, followed by a period without stimulation.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: February 21, 2017
    Assignee: SetPoint Medical Corporation
    Inventors: Jacob A. Levine, Michael A. Faltys, Ralph J. Zitnik
  • Publication number: 20160331952
    Abstract: An external programmer, such as an external clock synchronization tool, can be used to update or modify the stimulation protocol and/or parameters on an implanted electrical stimulator. In particular, described herein are external clock synchronization tools that can be used to calibrate a low-power clock of the implanted electrical stimulator. These tools may also be used to provide command overrides, including suspending or delaying neurostimulation, stopping neurostimulation, and/or on-demand neurostimulation.
    Type: Application
    Filed: May 12, 2016
    Publication date: November 17, 2016
    Inventors: Michael A. FALTYS, Jacob A. LEVINE, Jesse M. SIMON, Anthony ARNOLD
  • Publication number: 20160114165
    Abstract: Described herein are methods and systems for using EEG recordings to improve vagus nerve stimulation (VNS) therapy. In particular, described herein are methods and systems for using EEG recordings to detect P300 and/or activation of the nucleus basalis and/or the locus coeruleus to determine the efficacy of VNS. The EEG recordings can be used to provide feedback control to help optimize stimulation parameters and to screen for patients that respond well to VNS therapy.
    Type: Application
    Filed: October 23, 2015
    Publication date: April 28, 2016
    Inventors: Jacob A. LEVINE, Michael A. FALTYS
  • Publication number: 20160096016
    Abstract: Described herein are devices, systems and method of treating inflammation by vagus nerve stimulation and the delivery of an anti-inflammatory drug. In particular, described herein are methods of treating inflammation including the steps of stimulating a subject's inflammatory reflex to inhibit the immune response and administering an anti-inflammatory drug.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 7, 2016
    Inventors: Kevin J. TRACEY, Mauricio ROSAS-BALLINA, Michael A. FALTYS, Ralph J. ZITNIK
  • Publication number: 20160096017
    Abstract: Described herein are systems and methods for applying extremely low duty-cycle stimulation sufficient to treat chronic inflammation using feedback to adjust the off times between stimulations. In particular, the feedback include an assessment of the level of inflammation by the patient or the healthcare provider, or by measure the level of an inflammatory analyte or biomarker, or by detecting nerve activity correlated with inflammation.
    Type: Application
    Filed: December 14, 2015
    Publication date: April 7, 2016
    Inventors: Jacob A. LEVINE, Michael A. FALTYS
  • Publication number: 20160067497
    Abstract: Devices, systems and methods for the treatment of chronic inflammatory disorders that include an implantable microstimulator and an external charger/controller wherein the controller is configured to operate using closed-loop feedback.
    Type: Application
    Filed: April 10, 2014
    Publication date: March 10, 2016
    Applicant: SETPOINT MEDICAL CORPORATION
    Inventors: Jacob A. LEVINE, Michael A. FALTYS
  • Publication number: 20160051813
    Abstract: An extravascular nerve cuff that is configured to hold a leadless, integral, implantable microstimulator. The nerve cuff may include a cuff body having a pocket or pouch for removably receiving the implantable device within. The nerve cuff can be secured around the nerve such that the electrodes of the device are stably positioned relative to the nerve. Furthermore, the nerve cuff drives the majority of the current from the stimulation device into the nerve, while shielding surrounding tissues from unwanted stimulation.
    Type: Application
    Filed: November 3, 2015
    Publication date: February 25, 2016
    Inventors: Michael A. FALTYS, Roy C. MARTIN, Steven E. SCOTT, Gerald E. LOEB
  • Publication number: 20160038745
    Abstract: A system for treating chronic inflammation may include an implantable microstimulator, a wearable charger, and optionally an external controller. The implantable microstimulator may be implemented as a leadless neurostimulator implantable in communication with a cervical region of a vagus nerve. The microstimulator can address several types of stimulation including regular dose delivery. The wearable charger may be worn around the subject's neck to rapidly (<10 minutes per week) charge an implanted microstimulator. The external controller may be configured as a prescription pad that controls the dosing and activity of the microstimulator.
    Type: Application
    Filed: October 19, 2015
    Publication date: February 11, 2016
    Inventors: Michael A. FALTYS, Jesse M. SIMON, Yiming LIU